Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Front Cell Infect Microbiol
2022 Jan 01;12:921410. doi: 10.3389/fcimb.2022.921410.
Show Gene links
Show Anatomy links
Isolation, characterization, and functional study of extracellular vesicles derived from Leishmania tarentolae.
Shokouhy M
,
Sarvnaz H
,
Taslimi Y
,
Lajevardi MS
,
Habibzadeh S
,
Mizbani A
,
Shekari F
,
Behbahani M
,
Torrecilhas AC
,
Rafati S
.
???displayArticle.abstract???
Leishmania (L.) species are protozoan parasites with a complex life cycle consisting of a number of developmental forms that alternate between the sand fly vector and their host. The non-pathogenic species L. tarentolae is not able to induce an active infection in a human host. It has been observed that, in pathogenic species, extracellular vesicles (EVs) could exacerbate the infection. However, so far, there is no report on the identification, isolation, and characterization of L. tarentolae EVs. In this study, we have isolated and characterized EVs from L. tarentolae GFP+ (tEVs) along with L. major GFP+ as a reference and positive control. The EVs secreted by these two species demonstrated similar particle size distribution (approximately 200 nm) in scanning electron microscopy and nanoparticle tracking analysis. Moreover, the said EVs showed similar protein content, and GFP and GP63 proteins were detected in both using dot blot analysis. Furthermore, we could detect Leishmania-derived GP63 protein in THP-1 cells treated with tEVs. Interestingly, we observed a significant increase in the production of IFN-γ, TNF-α, and IL-1β, while there were no significant differences in IL-6 levels in THP-1 cells treated with tEVs following an infection with L. major compared with another group of macrophages that were treated with L. major EVs prior to the infection. Another exciting observation of this study was a significant decrease in parasite load in tEV-treated Leishmania-infected macrophages. In addition, in comparison with another group of Leishmania-infected macrophages which was not exposed to any EVs, tEV managed to increase IFN-γ and decrease IL-6 and the parasite burden. In conclusion, we report for the first time that L. tarentolae can release EVs and provide evidence that tEVs are able to control the infection in human macrophages, making them a great potential platform for drug delivery, at least for parasitic infections.
Abdossamadi,
Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice.
2017, Pubmed
Abdossamadi,
Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice.
2017,
Pubmed
Alvar,
Leishmaniasis worldwide and global estimates of its incidence.
2012,
Pubmed
Angelini,
Foetal bovine serum-derived exosomes affect yield and phenotype of human cardiac progenitor cell culture.
2016,
Pubmed
Aswad,
Depleting extracellular vesicles from fetal bovine serum alters proliferation and differentiation of skeletal muscle cells in vitro.
2016,
Pubmed
Atayde,
Exosome Secretion by the Parasitic Protozoan Leishmania within the Sand Fly Midgut.
2015,
Pubmed
Atayde,
Exploitation of the Leishmania exosomal pathway by Leishmania RNA virus 1.
2019,
Pubmed
Atayde,
Leishmania exosomes and other virulence factors: Impact on innate immune response and macrophage functions.
2016,
Pubmed
Barbosa,
Extracellular Vesicles Released by Leishmania (Leishmania) amazonensis Promote Disease Progression and Induce the Production of Different Cytokines in Macrophages and B-1 Cells.
2018,
Pubmed
,
Echinobase
Basile,
Recombinant protein expression in Leishmania tarentolae.
2009,
Pubmed
Baxter,
Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFNγ+LPS), M(IL-4) and M(IL-10) phenotypes.
2020,
Pubmed
Besteiro,
Protein turnover and differentiation in Leishmania.
2007,
Pubmed
Bolhassani,
Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies.
2011,
Pubmed
Bosch-Nicolau,
Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression.
2019,
Pubmed
Breton,
Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.
2005,
Pubmed
Campbell,
Identification of a gp63 surface glycoprotein in Leishmania tarentolae.
1992,
Pubmed
Castelli,
Exosome secretion by Leishmania infantum modulate the chemotactic behavior and cytokinic expression creating an environment permissive for early infection.
2019,
Pubmed
Cavallari,
Serum-derived extracellular vesicles (EVs) impact on vascular remodeling and prevent muscle damage in acute hind limb ischemia.
2017,
Pubmed
Cocucci,
Ectosomes and exosomes: shedding the confusion between extracellular vesicles.
2015,
Pubmed
Contreras,
Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63.
2010,
Pubmed
Corrales,
Deciphering the Leishmania exoproteome: what we know and what we can learn.
2010,
Pubmed
Cuervo,
Proteomic characterization of the released/secreted proteins of Leishmania (Viannia) braziliensis promastigotes.
2009,
Pubmed
Dayakar,
Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.
2019,
Pubmed
Dong,
Modulation of Host-Pathogen Communication by Extracellular Vesicles (EVs) of the Protozoan Parasite Leishmania.
2019,
Pubmed
Dong,
Extracellular vesicles and leishmaniasis: Current knowledge and promising avenues for future development.
2021,
Pubmed
Douanne,
Unravelling the proteomic signature of extracellular vesicles released by drug-resistant Leishmania infantum parasites.
2020,
Pubmed
Eitan,
Extracellular vesicle-depleted fetal bovine and human sera have reduced capacity to support cell growth.
2015,
Pubmed
Gannavaram,
miR-21 Expression Determines the Early Vaccine Immunity Induced by LdCen-/- Immunization.
2019,
Pubmed
Geiger,
Exocytosis and protein secretion in Trypanosoma.
2010,
Pubmed
Gessani,
IFN-gamma expression in macrophages and its possible biological significance.
1998,
Pubmed
Gimona,
Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.
2017,
Pubmed
Gioseffi,
Leishmania-infected macrophages release extracellular vesicles that can promote lesion development.
2020,
Pubmed
Gudbergsson,
Systematic review of factors influencing extracellular vesicle yield from cell cultures.
2016,
Pubmed
Hassani,
Temperature-induced protein secretion by Leishmania mexicana modulates macrophage signalling and function.
2011,
Pubmed
Heirwegh,
Sandfly Fever Sicilian Virus-Leishmania major co-infection modulates innate inflammatory response favoring myeloid cell infections and skin hyperinflammation.
2021,
Pubmed
Isnard,
Impact of Leishmania metalloprotease GP63 on macrophage signaling.
2012,
Pubmed
Kaneko,
The role of interleukin-1 in general pathology.
2019,
Pubmed
Katebi,
Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.
2015,
Pubmed
Khadir,
Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin.
2018,
Pubmed
Kima,
Interferon gamma in leishmaniasis.
2013,
Pubmed
Kraaij,
Human monocytes produce interferon-gamma upon stimulation with LPS.
2014,
Pubmed
Lambertz,
Small RNAs derived from tRNAs and rRNAs are highly enriched in exosomes from both old and new world Leishmania providing evidence for conserved exosomal RNA Packaging.
2015,
Pubmed
Li,
Serum-free culture alters the quantity and protein composition of neuroblastoma-derived extracellular vesicles.
2015,
Pubmed
Lobb,
Optimized exosome isolation protocol for cell culture supernatant and human plasma.
2015,
Pubmed
Maas,
Extracellular Vesicles: Unique Intercellular Delivery Vehicles.
2017,
Pubmed
Mendoza-Roldan,
Detection of Leishmania tarentolae in lizards, sand flies and dogs in southern Italy, where Leishmania infantum is endemic: hindrances and opportunities.
2021,
Pubmed
Meng,
Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn.
1997,
Pubmed
Mizbani,
Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.
2009,
Pubmed
Niimi,
Leishmania tarentolae for the Production of Multi-subunit Complexes.
2016,
Pubmed
Nogueira,
Immunomodulatory Properties of Leishmania Extracellular Vesicles During Host-Parasite Interaction: Differential Activation of TLRs and NF-κB Translocation by Dermotropic and Viscerotropic Species.
2020,
Pubmed
Raymond,
Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species.
2012,
Pubmed
Saljoughian,
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.
2013,
Pubmed
Seif,
EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.
2016,
Pubmed
Silverman,
Proteomic analysis of the secretome of Leishmania donovani.
2008,
Pubmed
Silverman,
An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages.
2010,
Pubmed
Silverman,
Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells.
2010,
Pubmed
Silverman,
Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection.
2011,
Pubmed
Sun,
Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro.
2014,
Pubmed
Szempruch,
Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia.
2016,
Pubmed
Théry,
Membrane vesicles as conveyors of immune responses.
2009,
Pubmed
Théry,
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.
2018,
Pubmed
,
Echinobase
Torrecilhas,
Extracellular Vesicles in Trypanosomatids: Host Cell Communication.
2020,
Pubmed
Trocoli Torrecilhas,
Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response.
2009,
Pubmed
Valdivia,
The Leishmania metaphylome: a comprehensive survey of Leishmania protein phylogenetic relationships.
2015,
Pubmed
Webber,
How pure are your vesicles?
2013,
Pubmed
Zahedifard,
Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen.
2014,
Pubmed
